|Bid||2.8200 x 900|
|Ask||4.2400 x 800|
|Day's Range||3.0000 - 3.0500|
|52 Week Range||2.7000 - 4.0000|
|Beta (3Y Monthly)||0.22|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 22, 2019 - Mar 25, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.55|
DOYLESTOWN, Pa., May 14, 2019 -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported net sales of $2.3 million for the three months ended March 31, 2019,.
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can make much more than 100% if the company does well. For example, the ProPhase Labs, Inc. (NASDAQ:PRPH) sh...
ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) announced a change in the reporting of dividends paid to its stockholders in 2018. The Company previously reported its 2018 distributions as taxable dividends. Following an earnings and profits analysis, the Company determined the 2018 distributions are now considered to be return of capital (non-dividend) distributions.
DOYLESTOWN, Pa., March 26, 2019 -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported its net sales from continuing operations were $13.1 million for the.
Every investor in ProPhase Labs, Inc. (NASDAQ:PRPH) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger, smaller, companies while huge companies tend Read More...
ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a vertically integrated manufacturer, marketer and distributor of a diversified range of over-the-counter dietary supplements (“ProPhase” or “Company”), announced today that Monica Brady has been promoted to the position of Chief Financial Officer. Ms. Brady has served as the Company’s Chief Accounting Officer since September 2017 and previously served as the Company’s Director of Finance since 2009. “We are pleased to announce Monica’s well-deserved promotion to Chief Financial Officer,” said Ted Karkus, Chairman and Chief Executive Officer of ProPhase.
ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a vertically integrated manufacturer, marketer and distributor of a diversified range of over-the-counter dietary supplements (“ProPhase” or “Company”), announced today that its Board of Directors has declared a special cash dividend in the amount of $0.25 per share on its common stock, payable on January 24, 2019 to stockholders of record as of January 10, 2019. This special cash dividend is the second such return of capital to stockholders this year, with a prior special dividend of $1.00 per share paid to ProPhase stockholders in June 2018. “We are very pleased to be able to reward our stockholders with this special cash dividend.
NEW YORK, Nov. 19, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
ProPhase Labs Inc (NASDAQ:PRPH), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is PRPH Read More...
DOYLESTOWN, Pennsylvania, Nov. 14, 2018 -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported its financial results for the three and nine months ended.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 20) Avanos Medical Inc (NYSE: AVNS ) Becton Dickinson and Co (NYSE: ...